AstraZeneca Rejects Pfizer’s $117B Offer as Too Low

AstraZeneca Rejects Pfizer’s $117B Offer as Too Low Play

May 19 (Bloomberg) -- AstraZeneca rejected another takeover offer from Pfizer as too low, leaving the companies in a stalemate over a deal that would create the world’s biggest drugmaker. Bloomberg’s Jeffrey McCracken reports on Bloomberg Television’s “Bloomberg Surveillance.” Financo CEO John Berg also speaks. (Source: Bloomberg)

blog comments powered by Disqus